Elegent Pharmaceuticals Limited

Elegent Pharmaceuticals Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24239MH1990PLC057214 Incorporated 11 July 1990 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed Public Limited Company pharma
Data last updated
Revenue · FY 2016
-
Latest filing
EBITDA · FY 2016
Locked
In full report
Net profit · FY 2016
Locked
In full report
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹4.39 Cr
Issued & subscribed
Open charges
₹20.51 Cr
Secured borrowings
Company age
36 yrs
Est. 1990
Last financials
Mar 2016
Balance sheet date

About Elegent Pharmaceuticals Limited

Data last updated: 14 July 2026

Elegent Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 11 July 1990, the company has been in operation for over 36 years.

Registered with ROC Mumbai under CIN L24239MH1990PLC057214. Listed.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹4.39 Cr. It is led by directors including Dhirendra Bhanulal Sanghavi and Manjula Bhanulal Sanghavi.

Last AGM: 30 September 2016. Financial statements filed for year ended 31 March 2016. Office: Room No. 9 Irani Chawl New Prabhadevi Temple Veer Savarkar Road, Mumbai, Maharashtra, India – 400025.

The company is associated with 1 brand - Elegant Pharmaceuticals. As per MCA filings, the company has open charges of ₹20.51 Cr on record.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company Details of Elegent Pharmaceuticals Limited
CIN L24239MH1990PLC057214
Registration Number 057214
Incorporation Date 11 July 1990
ROC Mumbai
Listing Status Listed
Company Status Active
Date of Last AGM 30 September 2016
Date of Balance Sheet 31 March 2016
Compliance Status Active Non-Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Room No. 9 Irani Chawl New Prabhadevi Temple Veer Savarkar Road, Mumbai, Maharashtra, India – 400025
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Elegent Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Elegent Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Elegent Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Elegent Pharmaceuticals Limited

Elegent Pharmaceuticals Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24239MH1990PLC057214, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24239MH1990PLC057214 Current
U24239MH1990PLC057214 Previous
L24239MH1990PTC057214 Previous

Associated Brands with Elegent Pharmaceuticals Limited

Elegent Pharmaceuticals Limited operates one associated brand: Elegant Pharmaceuticals. These brands represent Elegent Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures bulk drugs, APIs, and formulations for pharmaceutical and therapeutic markets. elegantpharma.com

Competitors & Alternatives of Elegent Pharmaceuticals Limited

Brands and companies operating in the same space as Elegent Pharmaceuticals Limited include Inventys, Viyash, Blue Jet Healthcare and 6 more.

Competitor Description Location Founded
Inventys Inventys Actives, advanced intermediates, and specialty chemicals are custom manufactured. Mumbai, India, India 2005
Viyash Viyash APIs and intermediates are manufactured by Viyash as a CDMO. Hyderabad, India, India 2019
Blue Jet Healthcare Blue Jet Healthcare CDMO focused on manufacturing, supplier, and development of intermediates & APIs Mumbai, India, India 1969
Ami organics Ami organics Advanced API intermediates are manufactured for pharmaceutical use. Surat, India, India 2007
Aparna Pharmaceuticals Aparna Pharmaceuticals API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. Hyderabad, India, India 2008
HuiSheng Biotech Pharmaceutical HuiSheng Biotech Pharmaceutical APIs, intermediates, and finished dosage forms are manufactured. Hangzhou, China, China 2004
DUDE CHEM DUDE CHEM CDMO focused on manufacturing of APIs and intermediates Berlin, Germany, Germany 2019
Enanti Labs Enanti Labs Enanti Labs produces pharmaceutical intermediates and APIs in India with quality focus. Hyderabad, India, India 2007
Hindys Lab Hindys Lab Manufactures and exports pharmaceutical intermediates for global markets. Hyderabad, India, India 2007

Auditor Details of Elegent Pharmaceuticals Limited

Elegent Pharmaceuticals Limited is audited by P C SURANA & CO for the financial year 2016. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
P C SURANA & CO Locked Locked Locked
Premium access

Complete auditor history for Elegent Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Elegent Pharmaceuticals Limited

Elegent Pharmaceuticals Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Dhirendra Bhanulal Sanghavi Managing Director 23 Mar 1992 34 Years 4 Months Current
Manjula Bhanulal Sanghavi Additional Director 29 Nov 2018 7 Years 8 Months Current
Tejas Baijukumar Desai Additional Director 29 Nov 2018 7 Years 8 Months Current

Financials of Elegent Pharmaceuticals Limited FY 2016 filings available

Premium access

Ten-year financial statements for Elegent Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Elegent Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Elegent Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Elegent Pharmaceuticals Limited

Open charges
₹20.51 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Bank of Baroda₹19.21 Cr
Union Bank of India₹1.30 Cr
Latest charge details
DateLenderAmountStatus
09 Feb 1996 Union Bank of India ₹50 Lakh Open
30 Jun 1995 Bank of Baroda ₹1.5 Cr Open
25 Feb 1995 Bank of Baroda ₹50 Lakh Open
24 Oct 1994 Union Bank of India ₹80 Lakh Open
12 Oct 1994 Bank of Baroda ₹5.26 Cr Open

Total charge records: 8 View all charges

Employees and EPFO Compliance at Elegent Pharmaceuticals Limited

View historical data on people associated with Elegent Pharmaceuticals Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Elegent Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Elegent Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Elegent Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Elegent Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Elegent Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Elegent Pharmaceuticals Limited

Premium access

MSME payment history for Elegent Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Elegent Pharmaceuticals Limited

Premium access

Corporate group structure for Elegent Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Elegent Pharmaceuticals Limited

Premium access

MCA filings and documents for Elegent Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Elegent Pharmaceuticals Limited

Directors
29 Nov 2018
Manjula Bhanulal Sanghavi was appointed as a Additional Director on 29 Nov 2018 & has been associated with this company since 7 years 8 months.
Directors
29 Nov 2018
Tejas Baijukumar Desai was appointed as a Additional Director on 29 Nov 2018 & has been associated with this company since 7 years 8 months.
Activity
30 Sep 2016
Elegent Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records.
Activity
31 Mar 2016
Elegent Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai I.
Charges
31 Jan 2008
A charge with Bank Of Baroda of Rs. 0.50 Cr registered on 25 Feb 1995 with Charge ID 90352324 was modified on 31 Jan 2008.
Charges
31 Jan 2008
A charge with Bank Of Baroda of Rs. 5.26 Cr registered on 12 Oct 1994 with Charge ID 90352292 was modified on 31 Jan 2008.

Frequently Asked Questions about Elegent Pharmaceuticals Limited

Elegent Pharmaceuticals Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 11 July 1990 (36+ years old) and is registered under CIN L24239MH1990PLC057214.

The current directors of Elegent Pharmaceuticals Limited are:

The primary industry of Elegent Pharmaceuticals Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Yes, Elegent Pharmaceuticals Limited is a listed company.

Elegent Pharmaceuticals Limited can be reached at the registered office: Room No. 9 Irani Chawl New Prabhadevi Temple Veer Savarkar Road, Mumbai, Maharashtra, India – 400025.

The authorised capital is ₹10 Cr, and the paid-up capital is ₹4.39 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available